A 43-year-old woman rolls slowly out of bed, having dreamt the night before of her fifth-grade classroom—a room she knew well before taking disability leave. She makes her daily plea for a treatment that will allow her to get to the grocery store without tripping over her own feet. Meanwhile, a seven-year-old girl wakes up to check her insulin level. She adjusts the pump attached to her abdomen and wonders whether she will be able to eat the school lunch today, and whether she will eventually lose her sight.
These stories of people suffering from Parkinson’s disease and juvenile diabetes represent the plight of real people. Stem cell research using human embryos might mean new mornings for people like these—people you and I know by name. If embryonic stem cell research (ECSR) can alleviate such suffering, then is it not consonant with the Good News?